An all-star panel of physicians and regulatory-compliance experts headlined Caris Healthcare’s seventh annual Leadership Development Institute on July 23–24 in Knoxville, Tennessee. Caris physicians, nurse practitioners and patient care managers heard from David Wooten, MD, on Prognostication in CHF and COPD; John Redden, MD, on Medications at the End of Life; Monica Crane, MD, on the Clinical Course and Management of Dementia; and Raul Couret, MD, on How to be an Efficient and Effective Hospice Medical Director. In addition, conference attendees heard from Charles Canaan of Palmetto GBA on Hot Topics in Medicare and Compliance and Bonita Ledgerwood, Caris Vice President of Patient Care, on Care Planning for the Hospice Patient.
For the second year in a row, Caris was able to provide continuing education credit hours through the University of Tennessee’s Graduate School of Medicine Continuing Education and Professional Development Department. The two-day event was held at the Haslam Business Building on the University of Tennessee campus.
Caris Clinical team members hearing from John Redden, MD, on Medications at the End-of-Life.
Caris Representatives also participate in the annual Leadership Development Institute.
In addition to the clinical staff, Caris Representatives also attended the event, participating in targeted sessions designed to ensure Caris Representatives act as strong, ethical advocates for access to high-quality end-of-life care.
“Caris Leadership Development Institutes have proven over the years to be vital to fulfilling our vision of being a world-class hospice in the communities we’re privileged to serve,” said Caris Founder and CEO Norman McRae. “The institutes provide a unique opportunity for clinical team members to learn from and collaborate with various disciplines across the company. With around 100 attendees, the weekend was a great success and we’re already beginning to plan for next year’s event based on feedback from this year’s attendees.”
“We appreciate the commitment Caris employees make every day to provide our patients with excellent end-of-life care,” McRae concluded.